Tardive dyskinesia can affect many areas of your life, including your social life and self-confidence. Learning how to manage these effects can help improve your overall well-being and daily ...

The first expert consensus recommendations centered on screening, diagnosing and screening tardive dyskinesia (TD) among ...

Differentiating tardive dyskinesia from other movement disorders can be challenging. "One major criterion is the history of exposure to neuroleptic medications," said Jeff Bronstein, MD, PhD, of the ...

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced the presentation of the first expert consensus recommendations focused on screening, diagnosis and treatment of tardive dyskinesia among ...

Neurocrine Biosciences (NASDAQ:NBIX) on Thursday announced new expert consensus recommendations aimed at improving the ...

Neurocrine Biosciences introduces updated clinical guidance targeting tardive dyskinesia management in older care populations ...

So one of the trials that I'm interested in watching is an extension trial of the IMPACT-TD registry that's currently going on and being done by Teva Pharmaceuticals, who are the manufacturers of ...

CONDITION. I I’M A DIRECT SUPPORT PROFESSIONAL WITH THE ARC OF CARROLL COUNTY. BETHANY CHALMERS LOVES HELPING PEOPLE AND CONNECTING WITH OTHERS. BUT THOSE CONNECTIONS BECAME MORE CHALLENGING AFTER SHE ...

Currently there are two FDA approved treatment options for tardive dyskinesia. There are two medications that are VMAT2 inhibitors. These are valbenazine (Ingrezza) and deutetrabenazine (Austedo) made ...

Researchers developed a standardized tool to assess the functional impact of tardive dyskinesia on patients. A standardized scale to assess the severity of symptoms in patients with tardive dyskinesia ...

Tardive dyskinesia is a hyperkinetic movement disorder that causes faces to move involuntarily and abnormally. It is considered to be a drug-induced movement disorder. Movements often occur in the ...